Outcomes of off-label drug uses in hospitals: a multicentric prospective study
about
Off-label use of targeted therapies in oncologyIt is time to review how unlicensed medicines are usedA Case of Interstitial Lung Disease Probably Related to Rituximab Treatment.[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].Off-Label Uses of Omalizumab.Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.
P2860
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@ast
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@en
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@nl
type
label
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@ast
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@en
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@nl
prefLabel
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@ast
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@en
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@nl
P2093
P2860
P1476
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
@en
P2093
A Valderrama
J Martínez
L Gratacós
P2860
P2888
P304
P356
10.1007/S00228-014-1746-2
P577
2014-09-09T00:00:00Z
P5875
P6179
1015684159